9 December 2024
US FDA accepts GSK’s submission for the use of Nucala (mepolizumab) in COPD GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA)…
6 December 2024
JAMES HALSTEAD PLC Chairman’s Statement to the Annual General Meeting James Halstead plc, UK manufacturer and global seller of commercial flooring, is holding its…
Keystone Positive Change Investment Trust plc Publication of Circular Recommended proposals for the reconstruction and voluntary winding up of the Company Introduction On 30…
AVI Global Trust – Annual overview from QuotedData 6th December 2024 Building on solid foundations AVI Global (AGT) continues to demonstrate the value of a clear strategy…
5 December 2024
Hargreaves Services plc (“Hargreaves”, the “Company” or the “Group”) Trading Update and Notice of Interim Results Hargreaves Services plc (AIM: HSP), a diversified group delivering services…
Sequoia Economic Infrastructure Income Fund Limited (the “Company”) STRONG INTEREST INCOME GENERATION FROM RESILIENT PORTFOLIO WELL POSITIONED TO DELIVER ATTRACTIVE AND SUSTAINABLE RETURNS Interim…
GSK and Zhifei revise and extend strategic vaccine collaboration in China GSK plc (LSE/NYSE: GSK) today announced that it has entered into an agreement…
Imfinzi approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer Based on ADRIATIC Phase III trial…